This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?
Slowly but surely, the company's prospects are looking more attractive. The past three years have been disappointing for Pfizer (PFE -0.74%): The drugmaker's revenue, earnings, and stock price have generally moved in the wrong direction. However, …